Laia Agell

发表

PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events

S. Serrano, J. Lloreta, M. Salido, 2011, Modern Pathology.

Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.

S. Serrano, J. Lloreta, S. Mojal, 2012, Human pathology.

Benefits of using a hybrid problem-based learning curriculum to improve long-term learning acquisition in undergraduate biology education.

J. Baños, Mar Carrió, E. Moyano, 2016, FEMS microbiology letters.

ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

L. Serrano, Alba Font-Tello, N. Juanpere, 2017, Oncotarget.

CXCR4 mRNA overexpression in high grade prostate tumors: lack of association with TMPRSS2-ERG rearrangement.

S. Serrano, J. Lloreta, M. Salido, 2012, Cancer biomarkers : section A of Disease markers.

A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.

S. Serrano, J. Lloreta, P. Fernández, 2012, The American journal of pathology.

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas

S. Serrano, J. Lloreta, M. Salido, 2010, Modern Pathology.

KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations

S. Serrano, J. Lloreta, J. Lorente, 2008, Modern Pathology.

FGFR3 mutations in prostate cancer: association with low-grade tumors

S. Serrano, J. Lloreta, S. Mojal, 2009, Modern Pathology.

Using Role Play to Debate Animal Testing

Laia Agell, M. Carrió, Vanessa Soria, 2015 .